CARA: Cara Therapeutics, Inc. Book Value per Share
Supply chain disruption risks for rare components and international patent complexities are impacting Cara Therapeutics, Inc. (CARA), while the GURU.Markets interface displays the book value per share, where 0.89 is the current value of the metric. The humanitarian status of biomedicine guarantees stability, and resilience to crises is ensured by the constant demand for renal pruritus therapy.
Summary analytical data breakdowns for caratherapeutics.com (CARA)
- current quotes and average value forecast:
- market capitalization information:
- business book valuation details:
- debt level and financial liquidity data:
Total Debt to Equity Ratio Cara Therapeutics, Inc.|CARA - Long-Term Debt to Capital|Short-Term Debt to Equity Cara Therapeutics|CARA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Cara Therapeutics, Inc.|CARA - Long-Term Debt|Company Short-Term Debts Cara Therapeutics|Quick Ratio caratherapeutics.com
- earnings and multiples data:
General company analysis:CARA - Cara Therapeutics, Inc
Professional issuer selection is based on comparing the market price with the actual net asset value per share. Book value per share data reflects the actual capital of Cara Therapeutics, Inc. (CARA), which is critical for assessing the biotech's resilience to geopolitical risks and rare component supply chain disruptions, allowing investors to promptly identify overvalued or distressed assets.
Main competitors
BIIB - Net Assets per Single Share|Accounting Value of a Share NBIX (Neurocrine Corp)|RGC: Book Value per Share|axsome.com (AXSM) - Book Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc.|Equity per Share XENE (Xenon Pharmaceuticals Inc.)|Book Value per Share VKTX|SUPN - Net Asset Value per Share|Catalyst Pharmaceuticals - Accounting Value per Share|Book Value per Share denalitherapeutics.com DNLI|HRMY - Net Assets per Single Share|Accounting Value of a Share BHVN (Biohaven Ltd)|Amylyx (AMLX) - Net Assets per Single Share|Net Asset Value per Share Trevi Corp (TRVI)|PRAX (Praxis Precision Medicines) - Book Value per Share|Accounting Value per Share anavex.com (AVXL)|Book Value per Share CBLL|Book Value per Share Prothena Corporation (PRTA)|Net Assets per Single Share Alector ALEC|Accounting Value of a Share ANNX|Omeros Corp. - Book Value per Share|NGNE - Book Value per Share|ACIU (AC Immune SA) - Accounting Value per Share|Voyager Therapeutics Inc - Accounting Value of a Share|Accounting Value per Share NMRA|SCLX (Scilex Holding Company, Inc.) - Book Price of a Share|Book Value per Share TVGN|ACOG (alphacognition.com) - Accounting Value of a Share|Book Value per Share CGTX (Cognition Therapeutics)|Inhibikase Therapeutics Inc (IKT) - Net Asset Value per Share|SAVA - Net Assets per Single Share|Accounting Value of a Share ASRT (Assertio Holdings, Inc.)|COYA: Book Value per Share|Vistagen (VTGN) - Book Value per Share|Net Assets per Single Share Ovid Therapeutics Inc|Acumen Pharmaceuticals Inc. - Share Book Value|Book Value per Share CRVO|ATHE - Net Asset Value per Share|Clene - Accounting Value per Share|Book Value per Share PepGen Inc PEPG|JUNS: Accounting Value per Share|Relmada Therapeutics Inc - Book Price of a Share|ANVS: Book Value per Share|GRCE - Net Assets per Share|AIFF (Firefly Neuroscience, Inc) - Book Value per Share|Accounting Value per Share ANEW Medical, Inc. (KLTO)|Net Assets per Single Share NeuroSense Therapeutics (NRSN)|Net Assets per Share Reviva Pharmaceuticals Holdings Inc.|MetaVia - Accounting Value per Share|Accounting Value of a Share NRXS|Helius Medical Technologies Inc. - Book Value per Share|Net Assets per Share Passage Bio, Inc. PASG|bionomics.com.au (NEUP) - Net Assets per Single Share|Equity per Share NERV|ATHA (Athira) - Book Value per Share|Accounting Value per Share Addex (ADXN)|Accounting Value per Share ALZN (Alzamend Neuro, Inc.)|Net Assets per Share cyclerion.com|Book Value per Share PTIX (Protagenic Therapeutics, Inc.)|KTTA - Accounting Value per Share|Cortigent Medical - Book Value per Share|ATXI - Book Value per Share|Brainstorm Cell (BCLI) - Net Assets per Single Share|chromocell.com - Accounting Value of a Share|ELYM (Eliem Therapeutics, Inc.) - Book Value per Share|Book Value per Share Intra-Cellular|Net Assets per Single Share Longboard Pharma (LBPH)|Marinus Pharma - Equity per Share|Book Value per Share NKGN (NKGen Biotech, Inc.)|neurobopharma.com (NRBO) - Net Asset Value per Share|SAGE: Accounting Value per Share|SNPX - Book Value per Share|Trevena, Inc (TRVN) - Net Assets per Single Share|Vigil Neuroscience, Inc. - Accounting Value of a Share|Net Assets per Single Share Anew Medical|Net Asset Value per Share cerevel.com CERE